Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Nucleosome changes associated with Cancer and NETosis related diseases

Wednesday, February 28, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The poster presented by Kelly et al at AGBT 2023 discusses nucleosome changes associated with cancer and NETosis-related diseases. This research may provide insights into the prognostic value of the Nu.Q® cancer test and its relevance to various health conditions. The findings could enhance understanding of disease mechanisms.
Price reaction · baseline $20.2 (2024-02-28T15:55:00.000Z) · hit during market hours · 5 other VNRX headline(s) in the window, move may be shared
day 0 close · peak
0%

Market Sentiment Analysis

POSITIVE FACTORS

  • Presentation at AGBT 2023 highlights important research.
  • Focus on nucleosome changes could lead to better cancer understanding.
  • Potential implications for NETosis related diseases.

Full Press Release Details

Poster titled: Nucleosome changes associated with Cancer and NETosis related diseases
Presented at AGBT 2023
Nucleosome changes associated with Cancer and NETosis related diseases by Kelly et al

Related Articles

• Press Releases Data Showing the Prognostic Value of its Nu.Q® Cancer Test
• Poster & Publications Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

Data Showing the Prognostic Value of its Nu.Q® Cancer Test

Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What was presented at AGBT 2023?

A poster on nucleosome changes associated with cancer and NETosis-related diseases.

Who conducted the research on nucleosome changes?

The research was conducted by Kelly et al.

What is the significance of the Nu.Q® cancer test?

It has prognostic value related to cancer detection and monitoring.

What diseases are linked to the nucleosome changes?

The changes are associated with cancer and NETosis-related diseases.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare cancer NETosis AGBT 2023 Nu.Q® cancer test
Last updated: Feb 28, 2024

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk